Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 51
Gene Symbol: ACOX1
ACOX1
0.100 Biomarker group HPO
Entrez Id: 49
Gene Symbol: ACR
ACR
0.010 Biomarker group BEFREE ACR Appropriateness Criteria<sup>®</sup> Dysphagia. 31054737 2019
Entrez Id: 58
Gene Symbol: ACTA1
ACTA1
0.100 Biomarker group HPO
Entrez Id: 60
Gene Symbol: ACTB
ACTB
0.100 Biomarker group HPO
Entrez Id: 72
Gene Symbol: ACTG2
ACTG2
0.100 Biomarker group HPO
Entrez Id: 103
Gene Symbol: ADAR
ADAR
0.100 Biomarker group HPO
Entrez Id: 120
Gene Symbol: ADD3
ADD3
0.100 Biomarker group HPO
Entrez Id: 126
Gene Symbol: ADH1C
ADH1C
0.100 Biomarker group HPO
Entrez Id: 10939
Gene Symbol: AFG3L2
AFG3L2
0.100 CausalMutation group CLINVAR Missense mutations in the AFG3L2 proteolytic domain account for ∼1.5% of European autosomal dominant cerebellar ataxias. 20725928 2010
Entrez Id: 10939
Gene Symbol: AFG3L2
AFG3L2
0.100 Biomarker group HPO
Entrez Id: 375790
Gene Symbol: AGRN
AGRN
0.100 Biomarker group HPO
Entrez Id: 23287
Gene Symbol: AGTPBP1
AGTPBP1
0.100 CausalMutation group CLINVAR
Entrez Id: 213
Gene Symbol: ALB
ALB
0.030 Biomarker group BEFREE Esophageal stent use resulted in a significant improvement in mean dysphagia scores in the immediate post stent period but failed to demonstrate any positive changes in weight, body mass index (BMI) or albumin. 31828290 2020
Entrez Id: 213
Gene Symbol: ALB
ALB
0.030 GeneticVariation group BEFREE The Access and No-Access cohorts had similar reported dysphagia (86% vs 75.5%, respectively; P = .2) and mean preesophagectomy serum albumin (3.9 vs 4 gm/dL, respectively; P = .2). 29198770 2018
Entrez Id: 213
Gene Symbol: ALB
ALB
0.030 AlteredExpression group BEFREE Subcutaneous edema, severe muscle weakness and dysphagia together with elevated creatine kinase, D-dimer and triglyceride levels, and decreased albumin levels were found in anti-NXP-2-positive DM. 31571350 2020
Entrez Id: 57679
Gene Symbol: ALS2
ALS2
0.100 Biomarker group HPO
Entrez Id: 29123
Gene Symbol: ANKRD11
ANKRD11
0.100 Biomarker group HPO
Entrez Id: 348
Gene Symbol: APOE
APOE
0.010 Biomarker group BEFREE As neurodegenerative processes are implicated in swallowing dysfunction, we hypothesized that the presence of ApoE 4 would be predictive of dysphagia symptoms in older adults. 24261350 2015
Entrez Id: 351
Gene Symbol: APP
APP
0.100 Biomarker group HPO
Entrez Id: 367
Gene Symbol: AR
AR
0.110 Biomarker group HPO
Entrez Id: 367
Gene Symbol: AR
AR
0.110 Biomarker group BEFREE A 15-year-old girl who underwent posterior instrumented fusion for AIS was admitted to our department 10 years later with a complaint of dysphagia due to an esophageal perforation from a malpositioned T4 pedicle screw (PS). 26633815 2017
Entrez Id: 57492
Gene Symbol: ARID1B
ARID1B
0.100 CausalMutation group CLINVAR
Entrez Id: 410
Gene Symbol: ARSA
ARSA
0.010 GeneticVariation group BEFREE Compared to controls, NUR-HV were younger (51.2 ± 16.8 years vs. 57.6 ± 15.2, p = 0.05), had a lower baseline BMI (28.2 ± 6.4 vs. 31.3 ± 5.4, p = 0.003) and ASA scores (p = 0.02), presented with higher GERSS (46 (28-60) vs. 35 (19-48), p = 0.02) and dysphagia scores (3 (1-5) vs. 2 (0-4), p = 0.02), were associated with LNF (77.7% vs. 54.6%, p = 0.02), and experienced more post-operative dysphagia (13.3% vs. 4.6%, p = 0.06). 31300909 2019
Entrez Id: 170302
Gene Symbol: ARX
ARX
0.100 Biomarker group HPO
Entrez Id: 51008
Gene Symbol: ASCC1
ASCC1
0.100 Biomarker group HPO